Get the Stockscreener App
2.64
0.00%
0.00
Anebulo Pharmaceuticals Inc stock is traded at $2.64, with a volume of 10,605.
It is up +0.00% in the last 24 hours and up +5.60% over the past month.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.
See More
Previous Close:
$2.64
Open:
$2.54
24h Volume:
10,605
Relative Volume:
0.13
Market Cap:
$108.46M
Revenue:
-
Net Income/Loss:
$-7.92M
P/E Ratio:
-8.80
EPS:
-0.3
Net Cash Flow:
$-7.05M
1W Performance:
-4.00%
1M Performance:
+5.60%
6M Performance:
+118.18%
1Y Performance:
+40.43%
1-Day Range:
$2.51
$2.64
1-Week Range:
$2.51
$2.76
52-Week Range:
$0.8001
$3.39
Anebulo Pharmaceuticals Inc Stock (ANEB) Company Profile
Name
Anebulo Pharmaceuticals Inc
Sector
Industry
Phone
737 203 5270
Address
C/O ANEBULO PHARMACEUTICALS, INC., LAKEWAY
Compare ANEB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ANEB
Anebulo Pharmaceuticals Inc
|
2.64 | 108.46M | 0 | -7.92M | -7.05M | -0.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Anebulo Pharmaceuticals Inc Stock (ANEB) Latest News
Top chart patterns to watch in Anebulo Pharmaceuticals Inc.2025 Trading Volume Trends & AI Driven Stock Reports - newser.com
What is the fair value of Anebulo Pharmaceuticals Inc. stock nowStock Surge & Expert Curated Trade Setups - newser.com
Has Anebulo Pharmaceuticals Inc. found a price floorJuly 2025 Opening Moves & Low Risk Investment Opportunities - newser.com
Is Anebulo Pharmaceuticals Inc. stock ready for a breakoutQuarterly Trade Summary & High Yield Stock Recommendations - newser.com
What Wall Street predicts for Anebulo Pharmaceuticals Inc. stock priceSell Signal & Weekly Return Optimization Alerts - newser.com
Is Anebulo Pharmaceuticals Inc. stock attractive for ETFsAnalyst Downgrade & Community Consensus Stock Picks - newser.com
Can Anebulo Pharmaceuticals Inc. stock double in next 5 yearsJuly 2025 EndofMonth & Growth Oriented Trading Recommendations - newser.com
Is Anebulo Pharmaceuticals Inc. stock resilient to inflation2025 Trading Recap & Risk Controlled Swing Alerts - newser.com
Will Anebulo Pharmaceuticals Inc. continue its uptrendJuly 2025 Analyst Calls & Real-Time Market Sentiment Reports - newser.com
Is it too late to sell Anebulo Pharmaceuticals Inc.July 2025 Trends & Technical Analysis for Trade Confirmation - newser.com
Will earnings trigger a reversal in Anebulo Pharmaceuticals Inc.July 2025 Technicals & High Accuracy Trade Signal Alerts - newser.com
Quantitative breakdown of Anebulo Pharmaceuticals Inc. recent moveQuarterly Market Summary & Daily Chart Pattern Signal Reports - newser.com
Custom watchlist performance reports with Anebulo Pharmaceuticals Inc.2025 Growth vs Value & Daily Volume Surge Trade Alerts - newser.com
How Anebulo Pharmaceuticals Inc. stock reacts to global recession fearsJuly 2025 News Drivers & AI Based Buy/Sell Signal Reports - newser.com
Is Anebulo Pharmaceuticals Inc. stock supported by strong cash flowsTrade Ideas & Expert Curated Trade Ideas - newser.com
Will Anebulo Pharmaceuticals Inc. stock attract ESG investorsJuly 2025 Selloffs & Free Real-Time Volume Trigger Notifications - newser.com
Will Anebulo Pharmaceuticals Inc. stock beat EPS estimatesMarket Sentiment Summary & Reliable Price Action Trade Plans - newser.com
Anebulo Pharmaceuticals’ Selonabant Study: Key Insights for Investors - TipRanks
How to recover losses in Anebulo Pharmaceuticals Inc. stockEarnings Growth Summary & Technical Pattern Based Buy Signals - newser.com
Analyzing net buyer seller activity in Anebulo Pharmaceuticals Inc.Weekly Loss Report & Community Verified Swing Trade Signals - newser.com
Is Anebulo Pharmaceuticals Inc. stock a buy for dividend growthEarnings Beat & High Conviction Buy Zone Picks - newser.com
Anebulo Pharmaceuticals Inc Stock (ANEB) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):